ERBB2 and breast cancer: To confirm these results, we analyzed STARD3 expression in BC subtypes (ER+ vs ER-); (PR- vs PgR+); (HER2+ vs HER2-) and (TNBC vs non-TNBC) using BC-GenExMiner v4.5.